dc.contributor.author |
Nxumalo, Precious Z
|
|
dc.contributor.author |
Takundwa, MM
|
|
dc.contributor.author |
Thimiri Govindaraj, Deepak B
|
|
dc.date.accessioned |
2021-10-09T08:58:44Z |
|
dc.date.available |
2021-10-09T08:58:44Z |
|
dc.date.issued |
2021-02 |
|
dc.identifier.citation |
Nxumalo, P.Z., Takundwa, M. & Thimiri Govinda Raj, D.B. 2021. Patents, ethics, biosafety and regulation using CRISPR technology. <i>Molecular Biology and Translational Science, 181.</i> http://hdl.handle.net/10204/12127 |
en_ZA |
dc.identifier.issn |
1877-1173 |
|
dc.identifier.uri |
https://doi.org/10.1016/bs.pmbts.2021.01.023
|
|
dc.identifier.uri |
http://hdl.handle.net/10204/12127
|
|
dc.description.abstract |
In this review chapter, we provide full comprehensive analysis on the patent, ethics and biosafety regulation with respect to the application of CRISPR technology in mammalian systems. We focused on recent development in CRISPR technology and its patent landscape between countries such as US, European Union, China and Australia. Further, we emphasized on the current scenarios on the ethics regulations with respect to CRISPR research, its applicability in patent and technology transfer. Finally, we elaborated on the biosafety regulation on CRISPR/Cas9 technology application in both mammalian and non-mammalian host system. |
en_US |
dc.format |
Abstract |
en_US |
dc.language.iso |
en |
en_US |
dc.relation.uri |
https://doi.org/10.1016/bs.pmbts.2021.01.023 |
en_US |
dc.relation.uri |
https://www.sciencedirect.com/science/article/abs/pii/S187711732100034X |
en_US |
dc.source |
Progress in Molecular Biology and Translational Science |
en_US |
dc.subject |
Ethics and biosafety regulation |
en_US |
dc.subject |
CRISPR technology |
en_US |
dc.title |
Patents, ethics, biosafety and regulation using CRISPR technology |
en_US |
dc.type |
Article |
en_US |
dc.description.pages |
345-365 |
en_US |
dc.description.note |
Copyright: 2021 Elsevier Inc. Due to copyright restrictions, the attached PDF file only contains the abstract of the full text item. For access to the full text item, please consult the publisher's website: https://www.sciencedirect.com/science/article/abs/pii/S187711732100034X |
en_US |
dc.description.cluster |
Next Generation Health |
en_US |
dc.description.impactarea |
Synthetic Nanobiotech Biomachs |
en_US |
dc.identifier.apacitation |
Nxumalo, P. Z., Takundwa, M., & Thimiri Govinda Raj, D. B. (2021). Patents, ethics, biosafety and regulation using CRISPR technology. <i>Molecular Biology and Translational Science, 181</i>, http://hdl.handle.net/10204/12127 |
en_ZA |
dc.identifier.chicagocitation |
Nxumalo, Precious Z, MM Takundwa, and Deepak B Thimiri Govinda Raj "Patents, ethics, biosafety and regulation using CRISPR technology." <i>Molecular Biology and Translational Science, 181</i> (2021) http://hdl.handle.net/10204/12127 |
en_ZA |
dc.identifier.vancouvercitation |
Nxumalo PZ, Takundwa M, Thimiri Govinda Raj DB. Patents, ethics, biosafety and regulation using CRISPR technology. Molecular Biology and Translational Science, 181. 2021; http://hdl.handle.net/10204/12127. |
en_ZA |
dc.identifier.ris |
TY - Article
AU - Nxumalo, Precious Z
AU - Takundwa, MM
AU - Thimiri Govinda Raj, Deepak B
AB - In this review chapter, we provide full comprehensive analysis on the patent, ethics and biosafety regulation with respect to the application of CRISPR technology in mammalian systems. We focused on recent development in CRISPR technology and its patent landscape between countries such as US, European Union, China and Australia. Further, we emphasized on the current scenarios on the ethics regulations with respect to CRISPR research, its applicability in patent and technology transfer. Finally, we elaborated on the biosafety regulation on CRISPR/Cas9 technology application in both mammalian and non-mammalian host system.
DA - 2021-02
DB - ResearchSpace
DP - CSIR
J1 - Molecular Biology and Translational Science, 181
KW - Ethics and biosafety regulation
KW - CRISPR technology
LK - https://researchspace.csir.co.za
PY - 2021
SM - 1877-1173
T1 - Patents, ethics, biosafety and regulation using CRISPR technology
TI - Patents, ethics, biosafety and regulation using CRISPR technology
UR - http://hdl.handle.net/10204/12127
ER - |
en_ZA |
dc.identifier.worklist |
24995 |
en_US |